CAS 652973-93-8

4-chloro-N-[(2S)-2-[1-(1-naphthyl)ethylamino]cyclohexyl]benzamide

Description:

4-chloro-N-[(2S)-2-[1-(1-naphthyl)ethylamino]cyclohexyl]benzamide, with CAS number 652973-93-8, is a chemical compound characterized by its complex structure, which includes a chloro group, a naphthyl moiety, and a cyclohexyl group. This compound is classified as a benzamide derivative, indicating that it contains a benzene ring attached to a carbonyl group (amide). The presence of the chiral center at the 2-position of the cyclohexyl group suggests that it may exhibit stereoisomerism, which can influence its biological activity and pharmacological properties. The compound is likely to be lipophilic due to the naphthyl and cyclohexyl groups, which may affect its solubility and permeability in biological systems. Additionally, the chloro substituent can impact its reactivity and interaction with biological targets. Overall, this compound may be of interest in medicinal chemistry, particularly in the development of pharmaceuticals targeting specific receptors or pathways.

Formula: C₂₅H₂₇ClN₂O

InChI: InChI=1/C25H27ClN2O/c1-17(21-10-6-8-18-7-2-3-9-22(18)21)27-23-11-4-5-12-24(23)28-25(29)19-13-15-20(26)16-14-19/h2-3,6-10,13-17,23-24,27H,4-5,11-12H2,1H3,(H,28,29)/t17?,23-,24?/m0/s1

SMILES: CC(c1cccc2ccccc12)N[C@H]1CCCCC1NC(=O)c1ccc(cc1)Cl

Calhex 231

Controlled Product

CAS: 652973-93-8

Applications A new calcium sensing receptor ligand demonstrating potent calcilytic activity.
References Ray, N., et al.: J. Bone Miner. Res., 12, 24 (1997), Sato, M., et al.: J. Med. Chem., 42, 1 (1999),Rodan, G., et al.: Science, 289, 1508 (2000), Goltzman, D., et al.: Nat. Rev. Drug Discov., 1, 784 (2002), Petrel, C., et al.: J. Biol. Chem., 279, 18990 (2004),

Formula: C₂₅H₂₇ClN₂O

Color and Shape: Neat

Molecular weight: 406.95

Ref: TR-C148000

Calhex 231

CAS: 652973-93-8

Calhex 231 is a synthetic peptide that belongs to the group of growth factors. It is a signal-transducing molecule that regulates cellular physiology by binding to its receptor, which activates intracellular calcium levels and cell proliferation. Calhex 231 has been shown to inhibit the proliferation of cardiac cells in an experimental model and to decrease tissue injury in a rat model of mesenteric ischemia. This drug also has anti-inflammatory effects, which may be due to its ability to induce autophagy.

Formula: C₂₅H₂₇ClN₂O

Purity: Min. 95%

Molecular weight: 406.95 g/mol

Ref: 3D-FC19636